Recent Trends in Targeted Anticancer Prodrug and Conjugate Design

E-ISSN： 1875-533x|15|18|1802-1826

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.18, 2008-08, pp. : 1802-1826

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Enzyme Prodrug Therapies

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 10, 2010-09 ,pp. : 887-904

Bentham Science Publishers

Access to resources Recommend Favorite

Design, Synthesis and In-Vitro Evaluation of Polymer-linked Prodrug of Methotrexate for the Targeted Delivery to the Colon

Letters in Drug Design & Discovery, Vol. 11, Iss. 5, 2014-06 ,pp. : 601-610

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Recent Trends in Anticancer Drug Development: Challenges and Opportunities

Current Medicinal Chemistry, Vol. 24, Iss. 42, 2018-01 ,pp. : 4727-4728

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Trends in 1,2,3-Triazolo-Nucleosides as Promising Anti-Infective and Anticancer Agents

Current Medicinal Chemistry, Vol. 22, Iss. 12, 2015-03 ,pp. : 1462-1499

Bentham Science Publishers

Access to resources Recommend Favorite

Prodrug Design of Phenolic Drugs

Current Pharmaceutical Design, Vol. 16, Iss. 18, 2010-06 ,pp. : 2033-2052

Bentham Science Publishers

Access to resources Recommend Favorite